Search results for: stx209

Home/Search: stx209

Need a new search?

If you didn't find what you were looking for, try a new search!

12 11, 2020

Bringing Your STX209 Data Home

By |2023-12-12T21:37:59-05:00Nov 12, 2020|Comments Off on Bringing Your STX209 Data Home

Bringing Your STX209 Data Home The National Fragile X Foundation, with the help of several professionals, has secured an agreement to obtain STX209 trial participant data through a reconsent process. We need a total [...]

16 05, 2013

Seaside Therapeutics Announces End of Arbaclofen (STX209) Extension Study

By |2013-05-16T11:03:00-04:00May 16, 2013|Keeping You Informed, News Reports and Commentaries, Seaside STX209|Comments Off on Seaside Therapeutics Announces End of Arbaclofen (STX209) Extension Study

Late yesterday afternoon the NFXF, along with all of the study locations, was contacted by Seaside Therapeutics and informed that the “Study 209FX303 [An Open-Label Extension Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of [...]

27 03, 2012

Seaside Therapeutics Announces Issuance of Key Patent for Lead Autism/FXS Candidate STX209

By |2012-03-27T13:52:35-04:00Mar 27, 2012|News Reports and Commentaries|Comments Off on Seaside Therapeutics Announces Issuance of Key Patent for Lead Autism/FXS Candidate STX209

New Patent Complements STX209 Orphan Drug Designation for Fragile X Syndrome CAMBRIDGE, Mass., Mar 27, 2012 (BUSINESS WIRE) -- Seaside Therapeutics, Inc. announced today that the United States Patent and Trademark Office (USPTO) has [...]

27 09, 2023

2023 Industry Updates — Webinar

By |2023-12-14T11:17:44-05:00Sep 27, 2023|Research, Webinar|Comments Off on 2023 Industry Updates — Webinar

The NFXF hosted a Fragile X research updates webinar with three of our industry partners working on treatments for Fragile X syndrome. Each shared the most up-to-date information on their research project(s) in a way that is understood by those who aren’t steeped in drug research day in and day out. A short Q&A followed each presentation.

20 09, 2021

NFXF Webinar: 2021 Industry Updates

By |2021-10-07T14:11:53-04:00Sep 20, 2021|Research|Comments Off on NFXF Webinar: 2021 Industry Updates

We held an NFXF Webinar with three of our industry partners working on treatments for Fragile X syndrome. Each shared the most up-to-date information on their research project(s) in a way that is understood by those who aren’t steeped in drug research day in and day out. A short Q&A followed each presentation.

12 11, 2020

NFXF Research Readiness Program

By |2023-08-29T13:54:31-04:00Nov 12, 2020|Comments Off on NFXF Research Readiness Program

NFXF Research Readiness Program Our mission has always been and continues to be providing unwavering support for every family affected by Fragile X, while relentlessly pursuing a cure. As a patient advocacy organization [...]

12 11, 2020

NFXF Data Repository

By |2023-11-03T12:54:12-04:00Nov 12, 2020|Comments Off on NFXF Data Repository

NFXF Data Repository Qualitative Survey Data Now Available! The NFXF Data Repository was created to help advance Fragile X research by making previously inaccessible, collected data available to researchers and investigators. By centralizing data [...]

Load More Posts